JAZZ vs RJET · P/E 1988, rev $2.28B vs P/E 10, rev $1.10B
Jazz Pharmaceuticals PLC (JAZZ) versus Republic Airways Holdings Inc (RJET) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Republic Airways Holdings Inc (RJET) is a airlines company listed on NASDAQ.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported RJET revenue for 2026-06-30 was $1.10B. Net income was $58.1M. RJET currently screens at market cap $848.1M and trailing P/E 10.2.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. RJET currently screens at market cap $848.1M and trailing P/E 10.2.
Not investment advice. Open the JAZZ and RJET stock pages for the full models.
Not investment advice.